Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology

Why is Quinidine Used for Brugada Syndrome?

At a Glance

Quinidine is a daily medication used to prevent life-threatening heart rhythms in patients with Brugada syndrome. It is especially useful for stopping frequent shocks from an implantable cardioverter-defibrillator (ICD) and serves as a vital therapy for children too small for an ICD.

Quinidine is a daily medication used to prevent life-threatening heart rhythms in patients with Brugada syndrome [1][2]. It works by blocking specific electrical pathways in the heart, balancing the heart’s electrical system to prevent the abnormal signals that trigger dangerous arrhythmias [3][4]. This medication is most commonly prescribed to quickly and effectively stop recurrent shocks from an implantable cardioverter-defibrillator (ICD), and for children who are too small to receive an ICD [5][6]. While it is highly effective, it does come with potential side effects like stomach upset or dizziness, though these can often be managed with your care team [3].

How Quinidine Works in the Heart

The heart relies on a precise flow of charged particles to maintain a steady, organized heartbeat. In Brugada syndrome, there is an imbalance in how these electrical signals travel across the wall of the heart’s lower pumping chambers [2].

Quinidine acts as an antiarrhythmic agent (a medication used to suppress abnormal heart rhythms) [1]. Its most important role in treating Brugada syndrome is blocking the Ito current, a specific pathway that allows potassium to exit heart cells [1][4]. In people with Brugada syndrome, this current is too strong, creating an uneven electrical gradient across the heart muscle [3][2]. This instability can spark a chaotic, dangerous rhythm called ventricular fibrillation [3].

By suppressing this outward potassium current, quinidine smooths out the electrical difference, significantly reducing the risk of a life-threatening arrhythmia [3][2]. The stabilizing effect of quinidine can often be seen on an electrocardiogram (EKG), where it may temporarily “normalize” the characteristic Brugada pattern [7].

When is Quinidine Prescribed?

Many patients with Brugada syndrome are treated with an Implantable Cardioverter-Defibrillator (ICD), a device that shocks the heart back into a normal rhythm if a dangerous arrhythmia occurs. However, an ICD does not prevent the arrhythmias from happening; it only treats them once they start.

Quinidine is typically recommended in specific situations where preventing these rhythms is necessary:

  • Frequent ICD Shocks: Some patients experience “electrical storms,” leading to multiple arrhythmias in a short period [8][9]. Quinidine is highly effective at stepping in to quickly calm the heart, stopping recurrent episodes and significantly improving quality of life for those burdened by frequent ICD shocks [5][3].
  • Pediatric Patients: Children with symptomatic Brugada syndrome are often too small for an ICD [6]. In these cases, quinidine is used as a primary daily therapy to prevent sudden cardiac events as they grow [10][11].
  • Alternative Options: For patients who cannot undergo or do not respond to catheter ablation (a procedure that destroys the abnormal tissue causing the rhythm problem), quinidine serves as a critical alternative [12][13]. Because quinidine is sometimes unavailable in certain regions, doctors may also consider alternative medications with similar effects [14].

What to Expect: Practicalities and Side Effects

Like all powerful medications, quinidine carries a risk of side effects. Long-term studies show that it is generally well-tolerated, and while some patients need to stop the medication, severe toxicity is relatively uncommon, especially when doctors use the lowest effective dose [3][15].

When taking quinidine, you and your doctor will monitor for:

  • Gastrointestinal Distress: Nausea, diarrhea, and stomach upset are the most frequent complaints [3]. Taking the daily medication with food or adjusting the dose can sometimes help manage these symptoms.
  • Cinchonism: This refers to a specific group of side effects caused by quinidine, which may include tinnitus (ringing in the ears), blurred vision, headache, and dizziness [3].
  • EKG Changes and Drug Interactions: Quinidine can alter another part of the heart’s electrical cycle, extending what is known as the QT interval on an EKG [16]. Because this carries a risk of a different dangerous arrhythmia called Torsades de Pointes, your care team will monitor your EKGs closely when starting or adjusting your dosage [16][17]. Additionally, quinidine can interact with other drugs. Always consult your pharmacist or doctor before taking new prescription or over-the-counter medications to prevent dangerous interactions.

Common questions in this guide

How does quinidine help treat Brugada syndrome?
Quinidine blocks specific electrical pathways in the heart, balancing the electrical system. This prevents the abnormal signals that can trigger dangerous, life-threatening arrhythmias associated with the condition.
Why would I need medication if I already have an ICD?
While an ICD treats dangerous arrhythmias after they start by shocking the heart, it does not prevent them from happening. Quinidine is prescribed to stop these abnormal rhythms from occurring in the first place, which helps prevent frequent and painful ICD shocks.
Can children with Brugada syndrome take quinidine?
Yes, quinidine is frequently used as a primary daily therapy for children with symptomatic Brugada syndrome. It is especially important for young patients who are too small to safely receive an implantable cardioverter-defibrillator.
What are the most common side effects of quinidine?
The most common side effects are gastrointestinal issues like nausea, diarrhea, and stomach upset. It can also cause a group of symptoms called cinchonism, which includes ringing in the ears, dizziness, blurred vision, and headaches.
Why do I need frequent EKGs while taking quinidine?
Quinidine can alter your heart's electrical cycle by extending what is known as the QT interval. Because this carries a risk of triggering a different type of dangerous arrhythmia, your doctor must monitor your EKGs closely to ensure the dosage remains safe.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific schedule for monitoring my EKG, particularly my QT interval, now that I am starting quinidine?
  2. 2.If I experience gastrointestinal side effects, how long should I wait before contacting you, and what can I safely do to manage them at home?
  3. 3.What is our backup plan if quinidine becomes difficult to source from local pharmacies due to supply shortages?
  4. 4.Are there any specific over-the-counter medications, supplements, or foods I must absolutely avoid to prevent interactions with quinidine?
  5. 5.For my child, how frequently will we need to recalculate and adjust their quinidine dosage as they grow?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Pharmacological Therapy in Brugada Syndrome.

    Brodie OT, Michowitz Y, Belhassen B

    Arrhythmia & electrophysiology review 2018; (7(2)):135-142 doi:10.15420/aer.2018.21.2.

    PMID: 29967687
  2. 2

    The Brugada syndrome: pharmacological therapy.

    Giustetto C, Cerrato N, Dusi V, et al.

    European heart journal supplements : journal of the European Society of Cardiology 2023; (25(Suppl C)):C32-C37 doi:10.1093/eurheartjsupp/suad036.

    PMID: 37125314
  3. 3

    Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience.

    Malhi N, Cheung CC, Deif B, et al.

    JACC. Clinical electrophysiology 2019; (5(3)):376-382 doi:10.1016/j.jacep.2018.10.007.

    PMID: 30898241
  4. 4

    Quinidine-A legacy within the modern era of antiarrhythmic therapy.

    Vitali Serdoz L, Rittger H, Furlanello F, Bastian D

    Pharmacological research 2019; (144()):257-263 doi:10.1016/j.phrs.2019.04.028.

    PMID: 31026503
  5. 5

    Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.

    Anguera I, García-Alberola A, Dallaglio P, et al.

    Journal of the American College of Cardiology 2016; (67(13)):1653-1654 doi:10.1016/j.jacc.2016.01.042.

    PMID: 27150692
  6. 6

    Brugada syndrome in the paediatric population: a comprehensive approach to clinical manifestations, diagnosis, and management.

    Gonzalez Corcia MC, de Asmundis C, Chierchia GB, Brugada P

    Cardiology in the young 2016; (26(6)):1044-55 doi:10.1017/S1047951116000548.

    PMID: 27151277
  7. 7

    Catheter Ablation for Brugada Syndrome.

    Qin D, Bode WD, Heist EK, et al.

    The Journal of innovations in cardiac rhythm management 2021; (12(5)):4520-4524 doi:10.19102/icrm.2021.120502.

    PMID: 34035984
  8. 8

    Arrhythmic storm from ischemic ventricular fibrillation treated with intravenous quinidine.

    Chorin E, Rosso R, Viskin D, et al.

    Journal of electrocardiology 2021; (68()):141-144 doi:10.1016/j.jelectrocard.2021.07.022.

    PMID: 34450448
  9. 9

    Incidence, recurrence and management of electrical storm in Brugada syndrome.

    El-Battrawy I, Roterberg G, Kowitz J, et al.

    Frontiers in cardiovascular medicine 2022; (9()):981715 doi:10.3389/fcvm.2022.981715.

    PMID: 36386327
  10. 10

    Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.

    Andorin A, Behr ER, Denjoy I, et al.

    Heart rhythm 2016; (13(6)):1274-82.

    PMID: 26921764
  11. 11

    Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome.

    Mazzanti A, Ovics P, Shauer A, et al.

    Journal of the American College of Cardiology 2019; (73(14)):1868-1869 doi:10.1016/j.jacc.2019.02.021.

    PMID: 30975305
  12. 12

    Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).

    Nademanee K, Chung FP, Sacher F, et al.

    Circulation 2023; (147(21)):1568-1578 doi:10.1161/CIRCULATIONAHA.122.063367.

    PMID: 36960730
  13. 13

    Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE).

    Nademanee K, Wongcharoen W, Chimparlee N, et al.

    Heart rhythm 2025; (22(8)):1975-1983 doi:10.1016/j.hrthm.2025.04.033.

    PMID: 40294736
  14. 14

    Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells.

    Zhang R, Jie LJ, Wu WY, et al.

    European journal of pharmacology 2019; (853()):74-83 doi:10.1016/j.ejphar.2019.03.029.

    PMID: 30880181
  15. 15

    Artemisinin-Quinidine Combination for Suppressing Ventricular Tachyarrhythmia in an Ex Vivo Model of Brugada Syndrome.

    Jeong HK, Yoon N, Kim YR, et al.

    Journal of Korean medical science 2025; (40(1)):e2 doi:10.3346/jkms.2025.40.e2.

    PMID: 39763307
  16. 16

    Influence of Gender on the Tolerability, Safety, and Efficacy of Quinidine Used for Treatment of Supraventricular and Ventricular Arrhythmias.

    Higgins AY, Waks JW, Josephson ME

    The American journal of cardiology 2015; (116(12)):1845-51.

    PMID: 26514302
  17. 17

    Assessment of Quinidine-Induced Torsades de Pointes Risks Using a Whole-Body Physiologically Based Pharmacokinetic Model Linked to Cardiac Ionic Current Inhibition.

    Zhang Z, Zhou H, Yang Y, et al.

    Clinical pharmacology and therapeutics 2024; (115(3)):616-626 doi:10.1002/cpt.3156.

    PMID: 38117225

This page provides educational information about using quinidine for Brugada syndrome. Always consult your cardiologist or electrophysiologist before starting, stopping, or adjusting your heart medications.

Get notified when new evidence is published on Brugada syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.